To establish evidence-based recommendations for the diagnosis and management of chronic prurigo (CPG), particularly in light of recent therapeutic advances that necessitate updated guidelines.
Key Findings:
CPG treatment should be personalized based on disease severity and patient-reported outcomes, with systemic options including biologics approved for CPG and additional off-label therapies.
CPG is characterized by intense pruritus and scratch-associated skin lesions, with a complex pathophysiology involving immune and neural mechanisms.
Interpretation:
The findings emphasize the need for standardized, evidence-based guidelines to improve CPG management, addressing both the clinical and psychological aspects of the disease, such as the impact of chronic itch on mental health.
Limitations:
Limited prevalence data for CPG in the Portuguese population, which may affect the generalizability of the findings.
Potential underdiagnosis due to overlapping symptoms with other dermatological diseases, which could lead to inadequate treatment and poorer patient outcomes.
Conclusion:
The consensus recommendations aim to provide dermatologists and healthcare professionals with a structured approach to optimize CPG diagnosis and treatment, ultimately improving patient care.
